INSIGHTS ON CLINICAL TRIAL PARTNERING

• GLP Compliance In A Modern Lab: What Is Actually Required?

  GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Breaking Silos In Drug Development: The Power Of An Integrated Model

  Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.

• What Sponsors Need To Know Before They Get To The IRB & IBC

  Gene therapy requires early, rigorous safety planning and command of pediatric and biosafety rules. Early committee engagement reduces delays and strengthens high‑stakes trials.

• Elevating Patient Centricity In Clinical Trials

  2/17/2025

  How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?

• From Legacy To Lifeline: Advancing Rare Disease Care

  6/13/2025

  Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.

• We Made Five Predictions For Clinical Research Last Year. Here's What Happened

  1/22/2026

  Review 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.

• The Shift Toward Self-Administration And Integrated Supply Chains

  4/15/2026

  Adopt integrated, end-to-end clinical supply strategies that enable self-administered therapies, reduce patient burden, and accelerate clinical trial timelines while improving access and outcomes.

• Paperless Online Remote Source Document Verification

  2/2/2026

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.